Protara Therapeutics, Inc. (TARA) stock
TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.32−0.06 (-2.52%)
Close on Nov 17, 2026Market cap $137.10MP/E –Yield –
Protara Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Protara Therapeutics's total debt was $0 at Dec 31, 2021. For fiscal 2021 it was $0.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $0 | – |
| FY2020 | Dec 31, 2020 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $370.79K | – |
| Q2 FY2020 | Jun 30, 2020 | $926.98K | – |
| Q1 FY2020 | Mar 31, 2020 | $1.30M | – |
See a number that looks wrong?